Cue Biopharma, Inc.
CUE
$0.56
-$0.01-1.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.42M | 27.96M | 14.05M | 23.39M | 32.42M |
| Total Receivables | 2.29M | 532.00K | -- | 945.00K | 3.15M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.11M | 2.35M | 1.88M | 805.00K | 1.68M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 25.82M | 30.84M | 15.93M | 25.14M | 37.26M |
|
|
|||||
| Total Current Assets | 25.82M | 30.84M | 15.93M | 25.14M | 37.26M |
| Net Property, Plant & Equipment | 4.91M | 5.57M | 4.11M | 4.84M | 4.60M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 916.00K | 4.29M | 2.21M | 2.21M | 2.95M |
| Total Assets | 31.64M | 40.71M | 22.25M | 32.19M | 44.81M |
|
|
|||||
| Total Accounts Payable | 2.35M | 3.63M | 3.78M | 2.82M | 6.47M |
| Total Accrued Expenses | 1.87M | 1.52M | 4.23M | 2.91M | 3.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.49M | 4.53M | 6.95M | 7.87M | 6.86M |
| Total Finance Division Other Current Liabilities | 7.82M | 9.58M | 535.00K | 85.00K | 259.00K |
| Total Other Current Liabilities | 7.82M | 9.58M | 535.00K | 85.00K | 259.00K |
| Total Current Liabilities | 15.52M | 19.25M | 15.50M | 13.69M | 16.79M |
|
|
|||||
| Total Current Liabilities | 15.52M | 19.25M | 15.50M | 13.69M | 16.79M |
| Long-Term Debt | -- | -- | -- | -- | 1.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.68M | 3.10M | 176.00K | 1.00M | 1.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 190.00K | 190.00K | -- | -- | -- |
| Total Liabilities | 18.40M | 22.55M | 15.67M | 14.69M | 19.44M |
|
|
|||||
| Common Stock & APIC | 383.30M | 380.76M | 360.70M | 359.36M | 357.73M |
| Retained Earnings | -370.05M | -362.60M | -354.12M | -341.86M | -332.37M |
| Treasury Stock & Other | 1.00K | -- | -- | -- | -- |
| Total Common Equity | 13.25M | 18.16M | 6.58M | 17.50M | 25.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.25M | 18.16M | 6.58M | 17.50M | 25.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.25M | 18.16M | 6.58M | 17.50M | 25.37M |
|
|
|||||